meRfi®-GM
The Digital Textbook on Gut Microbiota and Beyond
Multiple sclerosis (MS)
Welcome to meRfi-GM!
meRfi-GM provides you with up-to-date, evidence-based insights on the gut microbiota and related health topics.
Access our ever-expanding digital library and get personalized answers through our interactive AI chat platform.
Start your free trial and transform your understanding of the gut microbiota today!
Navigation
Contents
Multiple sclerosis (MS) is a chronic autoimmune disease of the central nervous system (CNS) characterized by neuroinflammation and neurodegeneration
Relapsing remitting Multiple Sclerosis (MS) (RRMS) is the most common clinical form of Multiple Sclerosis (MS) diagnosed in 85%–90% of patients between the ages 20–40, characterized by symptomatic attacks (relapses) followed by periods of recovery (remissions)
Relapsing remitting Multiple Sclerosis (MS) (RRMS) often transitions into seco…
References (Sources)
- A population-based study of multiple sclerosis in twins: Update
- Melatonin contributes to the seasonality of multiple sclerosis relapses
- Microglia in Central Nervous System Inflammation and Multiple Sclerosis Pathology
- Th1, Th17, and Th9 effector cells induce experimental autoimmune encephalomyelitis with different pathological phenotypes
- Th22 cells are expanded in multiple sclerosis and are resistant to IFN- β
- The changing demographic pattern of multiple sclerosis epidemiology
- The risk of smoking on multiple sclerosis: A meta-analysis based on 20,626 cases from case-control and cohort studies